[Biopython-dev] Subversion Repository

Chris Lasher chris.lasher at gmail.com
Sun Mar 18 17:02:03 UTC 2007

On 3/18/07, Ed Schofield <edschofield at gmail.com> wrote:
> Nice summary. How many "legacy users" will there be for whom moving to
> SVN would be a non-trivial task? This list is one channel for
> soliciting their feedback; are there any others?

I don't know, actually, how many "legacy users" we would have. The
other channel for soliciting feedback, and a very important one, is
the Biopython user list. That would probably be the best way of
assessing how many would still need to rely on CVS. Should I send an
email out to that list, or would one of the more senior developers
like to do it?


More information about the Biopython-dev mailing list